Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015, Neuland Laboratories has informed that it enclosed the schedule of Q4 & financial year ended March 31, 2024 Earnings Call details.
The above information is a part of company’s filings submitted to BSE.